Business & Industry
- Bayer and Aignostics to collaborate on next generation precision oncology
- AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
- European Commission approves Pfizer's PREVENAR 20® to help protect infants and children against pneumococcal disease
- Novartis presents new data on safety and efficacy of Zolgensma
- Pfizer announces positive top-line data for full season two efficacy of ABRYSVO® for RSV in older adults
Research & Development
- Novel molecules from generative AI to Phase II
- Key protein linked to immune disorders
- Researchers open new leads in anti-HIV drug development, using a compound found in nature
- Researchers discover new cancer-fighting role for neutrophils
- A smart molecule beats the mutation behind most pancreatic cancer
- Sildenafil (Viagra) as a candidate drug for Alzheimer's disease
- Cleveland Clinic researchers uncover how virus causes cancer, point to potential treatment
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA approves first gene therapies to treat patients with sickle cell disease
- FDA approves first therapy for rare type of non-cancerous tumors
- First electronic product information (ePI) published for selected human medicines
- FDA approves first treatment for patients with rare inherited blood clotting disorder
- FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants